Table 4.

Responder Rate Categorized by Baseline AIHS Baseline Severity, Median Treatment Volume, and Injection Instrument (mITT)

	VYC-15L (N = 103)
Baseline AIHS, no. (%)
Moderate	34/39 (87.2)
Severe	50/62 (80.6)
Treatment volume, no. (%)
≤Mediana	46/51 (90.2)
>Median	38/50 (76.0)
Injection instrument
27G 1½-inch cannula	52/56 (90.2)
32G ½-inch needle	32/45 (71.1)

AIHS, Allergan Infraorbital Hollow Scale; mITT, modified intent-to-treat; VYC-15L, Juvéderm Volbella XC.

^aMedian total volume injected for initial and touch-up treatments combined was 1.0 mL (range, 0.2-2.2 mL) for the left side and 1.0 mL (range, 0.1-2.2 mL) for the right side, with a total median of 1.5 mL (0.7 mL each side) for initial treatment and 1.0 mL (0.5 mL each side) for touch-up treatment.